Global Sepsis Therapeutics Market 2024-2028

Global Sepsis Therapeutics Market 2024-2028


The sepsis therapeutics market is forecasted to grow by USD 1.42 bn during 2023-2028, accelerating at a CAGR of 6.98% during the forecast period. The report on the sepsis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of sepsis, rising geriatric population globally, and improvements in healthcare infrastructure.

Technavio's sepsis therapeutics market is segmented as below:

By Application
  • Hospitals
  • Clinics
  • Others
By Type
  • Antimicrobial therapy
  • Adjunctive therapy
By Geographical Landscape
  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
This study identifies the increasing focus on use of precision medicine in sepsis treatment as one of the prime reasons driving the sepsis therapeutics market growth during the next few years. Also, new therapeutics development for sepsis treatment and advances in sepsis diagnosis and management will lead to sizable demand in the market.

The report on the sepsis therapeutics market covers the following areas:
  • Sepsis therapeutics market sizing
  • Sepsis therapeutics market forecast
  • Sepsis therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sepsis therapeutics market vendors that include Adrenomed AG, AM Pharma BV, Astellas Pharma Inc., AstraZeneca Plc, bioMerieux SA, CytoSorbents Corp., F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc, Inotrem S.A., Novartis AG, Pfizer Inc., Sanofi SA, Spectral Medical Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the sepsis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global sepsis therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global sepsis therapeutics market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Clinics - Market size and forecast 2023-2028
Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)
Exhibit 47: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Antimicrobial therapy - Market size and forecast 2023-2028
Exhibit 52: Chart on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
7.4 Adjunctive therapy - Market size and forecast 2023-2028
Exhibit 56: Chart on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ billion)
Exhibit 61: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 APAC - Market size and forecast 2023-2028
Exhibit 75: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on APAC - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on APAC - Year-over-year growth 2023-2028 (%)
9.6 South America - Market size and forecast 2023-2028
Exhibit 79: Chart on South America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on South America - Year-over-year growth 2023-2028 (%)
9.7 Middle East and Africa - Market size and forecast 2023-2028
Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
9.8 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Adrenomed AG
Exhibit 115: Adrenomed AG - Overview
Exhibit 116: Adrenomed AG - Product / Service
Exhibit 117: Adrenomed AG - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 118: Astellas Pharma Inc. - Overview
Exhibit 119: Astellas Pharma Inc. - Product / Service
Exhibit 120: Astellas Pharma Inc. - Key news
Exhibit 121: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 122: AstraZeneca Plc - Overview
Exhibit 123: AstraZeneca Plc - Product / Service
Exhibit 124: AstraZeneca Plc - Key news
Exhibit 125: AstraZeneca Plc - Key offerings
12.6 bioMerieux SA
Exhibit 126: bioMerieux SA - Overview
Exhibit 127: bioMerieux SA - Product / Service
Exhibit 128: bioMerieux SA - Key offerings
12.7 CytoSorbents Corp.
Exhibit 129: CytoSorbents Corp. - Overview
Exhibit 130: CytoSorbents Corp. - Product / Service
Exhibit 131: CytoSorbents Corp. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Hikma Pharmaceuticals Plc
Exhibit 137: Hikma Pharmaceuticals Plc - Overview
Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
12.10 Inotrem S.A.
Exhibit 141: Inotrem S.A. - Overview
Exhibit 142: Inotrem S.A. - Product / Service
Exhibit 143: Inotrem S.A. - Key offerings
12.11 Novartis AG
Exhibit 144: Novartis AG - Overview
Exhibit 145: Novartis AG - Business segments
Exhibit 146: Novartis AG - Key offerings
Exhibit 147: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 148: Pfizer Inc. - Overview
Exhibit 149: Pfizer Inc. - Product / Service
Exhibit 150: Pfizer Inc. - Key news
Exhibit 151: Pfizer Inc. - Key offerings
12.13 Sanofi SA
Exhibit 152: Sanofi SA - Overview
Exhibit 153: Sanofi SA - Business segments
Exhibit 154: Sanofi SA - Key news
Exhibit 155: Sanofi SA - Key offerings
Exhibit 156: Sanofi SA - Segment focus
12.14 Spectral Medical Inc.
Exhibit 157: Spectral Medical Inc. - Overview
Exhibit 158: Spectral Medical Inc. - Product / Service
Exhibit 159: Spectral Medical Inc. - Key offerings
12.15 Takeda Pharmaceutical Co. Ltd.
Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 169: Viatris Inc. - Overview
Exhibit 170: Viatris Inc. - Business segments
Exhibit 171: Viatris Inc. - Key news
Exhibit 172: Viatris Inc. - Key offerings
Exhibit 173: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global sepsis therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Type - Market share 2023-2028 (%)
Exhibits49: Data Table on Type - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Type ($ billion)
Exhibits61: Data Table on Market opportunity by Type ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on APAC - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on APAC - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on South America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on South America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Adrenomed AG - Overview
Exhibits116: Adrenomed AG - Product / Service
Exhibits117: Adrenomed AG - Key offerings
Exhibits118: Astellas Pharma Inc. - Overview
Exhibits119: Astellas Pharma Inc. - Product / Service
Exhibits120: Astellas Pharma Inc. - Key news
Exhibits121: Astellas Pharma Inc. - Key offerings
Exhibits122: AstraZeneca Plc - Overview
Exhibits123: AstraZeneca Plc - Product / Service
Exhibits124: AstraZeneca Plc - Key news
Exhibits125: AstraZeneca Plc - Key offerings
Exhibits126: bioMerieux SA - Overview
Exhibits127: bioMerieux SA - Product / Service
Exhibits128: bioMerieux SA - Key offerings
Exhibits129: CytoSorbents Corp. - Overview
Exhibits130: CytoSorbents Corp. - Product / Service
Exhibits131: CytoSorbents Corp. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Overview
Exhibits133: F. Hoffmann La Roche Ltd. - Business segments
Exhibits134: F. Hoffmann La Roche Ltd. - Key news
Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits137: Hikma Pharmaceuticals Plc - Overview
Exhibits138: Hikma Pharmaceuticals Plc - Business segments
Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits141: Inotrem S.A. - Overview
Exhibits142: Inotrem S.A. - Product / Service
Exhibits143: Inotrem S.A. - Key offerings
Exhibits144: Novartis AG - Overview
Exhibits145: Novartis AG - Business segments
Exhibits146: Novartis AG - Key offerings
Exhibits147: Novartis AG - Segment focus
Exhibits148: Pfizer Inc. - Overview
Exhibits149: Pfizer Inc. - Product / Service
Exhibits150: Pfizer Inc. - Key news
Exhibits151: Pfizer Inc. - Key offerings
Exhibits152: Sanofi SA - Overview
Exhibits153: Sanofi SA - Business segments
Exhibits154: Sanofi SA - Key news
Exhibits155: Sanofi SA - Key offerings
Exhibits156: Sanofi SA - Segment focus
Exhibits157: Spectral Medical Inc. - Overview
Exhibits158: Spectral Medical Inc. - Product / Service
Exhibits159: Spectral Medical Inc. - Key offerings
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits161: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits162: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits163: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits169: Viatris Inc. - Overview
Exhibits170: Viatris Inc. - Business segments
Exhibits171: Viatris Inc. - Key news
Exhibits172: Viatris Inc. - Key offerings
Exhibits173: Viatris Inc. - Segment focus
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings